Evaluation of OCT biomarker changes in treatment-naive neovascular AMD using a deep semantic segmentation algorithm

Ben Asani1, Olle Holmberg2, Johannes B Schiefelbein3

  • 1Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany. ben.asani@med.uni-muenchen.de.

Eye (London, England)
|July 27, 2024
PubMed
Summary

A novel deep learning algorithm accurately quantifies changes in OCT biomarkers for neovascular age-related macular degeneration (nAMD) patients undergoing anti-VEGF therapy. Significant fluid reduction occurs within 3 months, but RPE loss suggests potential long-term visual decline.

Related Concept Videos